Adverse events associated with rush Hymenoptera venom immunotherapy

---

• 1.
• Solley GO. Allergy to sting and biting insects in Queensland. Med J Aust 1990; 153: 650-654.
• 2.
• Reisman RE, Mueller UR, Wypych JI, Lazell MI. Studies of co-existing honeybee and vespid venom sensitivity. J Allergy Clin Immunol 1984; 73: 246-252.
• 3.
• Harvey P, Sperber S, Kettle F, et al. Bee sting mortality in Australia. Med J Aust 1984; 140: 209-211.
• 4.
• Müller U, Helbling A, Berchtold E. Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safety. J Allergy Clin Immunol 1992; 89: 529-535.
• 5.
• Golden DBK, Valentine MD, Kagay-Sobolka A, Lichtenstein LM. Regimens of hymenoptera venom immunotherapy. Ann Intern Med 1980; 92: 620-624.
• 6.
• Nataf P, Guinnepain MT, Herman D. Rush-venom immunotherapy: a 3-day programme for hymenoptera sting allergy. Clin Allergy 1984; 14: 269-275.
• 7.
• Van der Zwan JC, Flinterrman J, Jankowski IJ, Kerckhaert JA. Hyposensitisation to wasp venom in six hours. Br Med J 1983; 287: 1329-1331.
• 8.
• Gillman SA, Cummins LH, Kozak PP, Hoffman DR. Venom immunotherapy: comparison of "rush" vs "conventional" schedules. Annals of Allergy 1980; 45: 351-354.
• 9.
• Mueller HL. Diagnosis and treatment of insect sensitivity. J Asthma Res 1966; 3: 331-333.
• 10.
• American Academy of Allergy Committee on Insects. In: Levine MI, Lockey RF, editors. Monograph on insect allergy. Library of Congress Catalog Publication Data. Hartland, Wis: Parker Printing of Hartland, 1981.
• 11.
• SAS statistical package [computer program]. Version 6.12. Cary, NC: SAS Institute, 1996.
• 12.
• Roberts-Thompson PJ, Harvey P, Sperber S, et al. Bee sting anaphylaxis in an urban population of South Australia. Asia Pac J Allergy Immunol 1985; 3: 161-164.
• 13.
• Lui CL, Heddle RJ, Kupa A, et al. Bee venom hypersensitivity and its management: patients perception of venom desensitisation. Asia Pac J Allergy Immunol 1995; 13: 95-100.
• 14.
• Birnbaum J, Charpin D, Verloet D. Rapid Hymenoptera venom immunotherapy. Comparative safety of three protocols. Clin Exp Allergy 1993; 23: 226-230.
• 15.
• Thurnheer U, Müller U, Stoller R, et al. Venom immunotherapy in Hymenoptera sting allergy. Comparison of rush and conventional hyposensitization and observations during long-term treatment. Allergy 1983; 38: 465-475.
• 16.
• Bousquet J, Muller UR, Dreborg S, et al. Immunotherapy with Hymenoptera venoms. Allergy 1987; 42: 401-413.
• 17.
• Bernstein DI, Mittman RJ, Kagan SL, et al. Clinical and immunologic studies of rapid venom immunotherapy in Hymenoptera-sensitive patients. J Allergy Clin Immunol 1989; 84: 951-959.
• 18.
• Youlten LJ, Atkinson BA, Lee TH. The incidence and nature of adverse reactions to injection immunotherapy in bee and wasp venom allergy. Clin Exp Allergy 1995; 25: 159-165.
• 19.
• Yunginger JW, Paull BR, Jones RT, Santrach PJ. Rush immunotherapy programs for honeybee sting sensitivity. J Allergy Clin Immunol 1979; 63: 340-347.
• 20.
• van der Linden PW, Struyvenberg A, Kraaijenhagen RJ, et al. Anaphylactic shock after insect-sting challenge in 138 persons with a previous insect-sting reaction. Ann Intern Med 1993, 118: 161-168.
• 21.
• Visscher PK, Vetter RS, Camazine S. Removing bee stings. Lancet 1996; 348: 301-302.
• 22.
• Bernstein JA, Kagen SL, Bernstein DI, Bernstein IL. Rapid venom immunotherapy is safe for routine use in the treatment of patients with hymenoptera anaphylaxis. Ann Allergy 1994; 73: 423-428.
• 23.
• Committee on the Safety of Medicines. CSM update: desensitising vaccines. BMJ 1986; 293: 948.